Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS · Delayed Price · Currency is USD
0.0295
-0.0005 (-1.67%)
Apr 28, 2026, 9:30 AM EST

PLSH Revenue

Panacea Life Sciences Holdings had revenue of $1.06M in the quarter ending March 31, 2024, with 55.94% growth. This brings the company's revenue in the last twelve months to $2.76M, up 50.38% year-over-year. In the year 2023, Panacea Life Sciences Holdings had annual revenue of $2.38M with 46.59% growth.

Revenue (ttm)
2.76M
Revenue Growth
+50.38%
P/S Ratio
0.63
Revenue / Employee
69.10K
Employees
40
Market Cap
1.75M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.38M757.98K46.59%
Dec 31, 20221.63M-432.65K-21.01%
Dec 31, 20212.06M-6.96M-77.16%
Dec 31, 20209.02M6.82M310.19%
Dec 31, 20192.20M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nascent Pharma Holdings 1.03M
Procyon 4.98M
CannaPharmaRX 1.36M
Sibannac 434.00
Premier Biomedical 14.28K
Nutra Pharma 452.77K
Anything Technologies Media 257.70K
CBD Life Sciences 178.45K
Revenue Rankings